Preclinical-stage biotechnology · Tucson, Arizona
Sonoran Desert
drug discovery.
T-Hawk Life Sciences℠ turns venom peptides from Arizona's desert arthropods into precision therapeutics for pain, antimicrobial resistance, and neurological disease.
400M+ years
of natural selection tuning venom peptides to specific ion channels
at nanomolar affinity.
4 lineages
Structurally independent Sonoran arthropod peptide families converge
on the same human drug targets.
1 desert
One of the world's richest arthropod biodiversity zones, and one of
the least characterized. No competitor is mining it systematically.
Start here
The pages that follow lay out the strategy, the team, the medical need, the biology, the platform, and the pipeline, in that order. Use Next at the bottom of each page, or the Index in the upper corner to jump anywhere.